← Leaderboards
Edward V Nunes
Columbia University Health Sciences
$88,947,598
Attributed
$178,957,586
Total exposure
19
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $51.2M · FY2005–25$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$301,224,715 · 20
By mechanism
UG1$133,951,216 · 4
UM1$76,500,207 · 1
U10$47,600,346 · 1
UH3$12,060,583 · 1
R01$10,211,201 · 4
UG3$8,662,605 · 2
Top collaborators
- John P Rotrosen67 shared
- Adam Mariusz Bisaga6 shared
- Katherine S Elkington6 shared
- Jennifer Mcneely6 shared
- Milton L Wainberg6 shared
- Kathleen Theresa Brady4 shared
- Aimee N Campbell4 shared
- Nabila El-Bassel4 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Maria A Sullivan$5,868,043
Others in their field
Top investigators on “Communities”
- Eric S Lander · Whitehead Institute For Biomedical Res$547,749,172
- David Heimbrook · Leidos Biomedical Research, Inc.$526,770,200
- Larry Arthur$517,751,165
- Lawrence Corey · Fred Hutchinson Cancer Center$484,622,485
- David R. Weir · University Of Michigan At Ann Arbor$394,331,036
- Albert Lazzarini · California Institute Of Technology$381,143,533
Research focus
CommunitiesPharmaceutical PreparationsClinical TrialsBehavior TherapyTrainingBaseInnovationResearch PersonnelAddictionTreatment ProgramClinical Trials NetworkNational Institute Of Drug AbuseAdoptionMedicalNew YorkFundingLeadershipAreaLong IslandFutureServicesProviderPharmacotherapyPrograms
Grant awards (170)
NIDA Clinical Trials Network: New York Node (CTN-0139, CTN-0155, CTN-Biostats)$5,143,521
UG1 · FY2025 · DA
NIDA Clinical Trials Network: New York Node - Renewal-GY24$848,545
UG1 · FY2025 · DA
NIDA Clinical Trials Network: New York Node$4,199,171
UG1 · FY2024 · DA
Targeting Treatment-Resistant OUD with Ketamine-Assisted Mindfulness-Oriented Recovery Enhancement$1,837,542
UG3 · FY2024 · DA
NIDA Clinical Trials Network: New York Node$16,012,181
UG1 · FY2023 · DA
Evaluation of safety and pharmacokinetics of naltrexone implant$3,864,542
UH3 · FY2023 · DA
NIDA Clinical Trials Network: New York Node$2,867,419
UG1 · FY2023 · DA
Facilitating Opioid Care Connections: System level strategies to improve use of MAT and movement through the opioid care cascade for defendants in a new Opioid Court system$1,250,707
UG1 · FY2023 · DA
NIDA Clinical Trials Network: New York Node - GY22 Integrating MOUD in Non-Medical Settings to Improve Treatment and Retention of Black/AA Persons$61,306
UG1 · FY2023 · DA
NIDA Clinical Trials Network: New York Node$12,250,844
UG1 · FY2022 · DA
CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York State$8,680,000
UM1 · FY2022 · DA
Evaluation of safety and pharmacokinetics of naltrexone implant$4,087,023
UH3 · FY2022 · DA
NIDA Clinical Trials Network: New York Node$2,693,487
UG1 · FY2022 · DA
NIDA Clinical Trials Network: New York Node$2,068,510
UG1 · FY2022 · DA
Facilitating Opioid Care Connections: System level strategies to improve use of MAT and movement through the opioid care cascade for defendants in a new Opioid Court system$1,533,776
UG1 · FY2022 · DA
Coordinated medical treatment of opioid use disorder and infectious disease$1,267,815
U01 · FY2022 · TR
NIDA Clinical Trials Network: New York Node$708,249
UG1 · FY2022 · DA
NIDA Clinical Trials Network: New York Node$301,149
UG1 · FY2022 · DA
Leveraging Social Networks to Increase COVID-19 Testing Uptake: A Comparison of Credible Messenger and Chain Referral Recruitment Approaches$210,209
UG1 · FY2022 · DA
CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York State$23,218,255
UM1 · FY2021 · DA
NIDA Clinical Trials Network: New York Node$12,351,705
UG1 · FY2021 · DA
Evaluation of safety and pharmacokinetics of naltrexone implant$4,109,018
UH3 · FY2021 · DA
NIDA Clinical Trials Network: New York Node$2,294,405
UG1 · FY2021 · DA
NIDA Clinical Trials Network: New York Node$1,990,902
UG1 · FY2021 · DA
Facilitating Opioid Care Connections: System level strategies to improve use of MAT and movement through the opioid care cascade for defendants in a new Opioid Court system$1,685,517
UG1 · FY2021 · DA
NIDA Clinical Trials Network: New York Node$1,503,743
UG1 · FY2021 · DA
Coordinated medical treatment of opioid use disorder and infectious disease$1,347,367
U01 · FY2021 · TR
NIDA Clinical Trials Network: New York Node$1,000,000
UG1 · FY2021 · DA
NIDA Clinical Trials Network: New York Node$157,384
UG1 · FY2021 · DA
CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York State$22,091,108
UM1 · FY2020 · DA
NIDA Clinical Trials Network: New York Node$8,461,097
UG1 · FY2020 · DA
NIDA Clinical Trials Network: New York Node$4,613,577
UG1 · FY2020 · DA
NIDA Clinical Trials Network: New York Node$2,448,086
UG1 · FY2020 · DA
Facilitating Opioid Care Connections: System level strategies to improve use of MAT and movement through the opioid care cascade for defendants in a new Opioid Court system$1,953,777
UG1 · FY2020 · DA
NIDA Clinical Trials Network: New York Node$1,419,813
UG1 · FY2020 · DA
Coordinated medical treatment of opioid use disorder and infectious disease$1,353,900
U01 · FY2020 · TR
NIDA Clinical Trials Network: New York Node$730,885
UG1 · FY2020 · DA
Comprehensive CBT via reSET for a Hub and Spoke MAT System of Care$686,122
R33 · FY2020 · AT
CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York State$22,510,844
UM1 · FY2019 · DA
NIDA Clinical Trials Network: Greater New York Node$8,118,212
UG1 · FY2019 · DA
Evaluation of safety and pharmacokinetics of naltrexone implant$3,713,497
UG3 · FY2019 · DA
NIDA Clinical Trials Network: Greater New York Node$2,740,413
UG1 · FY2019 · DA
NIDA Clinical Trials Network: Greater New York Node$2,533,075
UG1 · FY2019 · DA
NIDA Clinical Trials Network: Greater New York Node$2,054,565
UG1 · FY2019 · DA
Facilitating Opioid Care Connections: System level strategies to improve use of MAT and movement through the opioid care cascade for defendants in a new Opioid Court system$2,043,447
UG1 · FY2019 · DA
NIDA Clinical Trials Network: Greater New York Node$1,974,434
UG1 · FY2019 · DA
Coordinated medical treatment of opioid use disorder and infectious disease$1,450,097
U01 · FY2019 · TR
NIDA Clinical Trials Network: Greater New York Node$973,826
UG1 · FY2019 · DA
NIDA Clinical Trials Network: Greater New York Node$759,467
UG1 · FY2019 · DA
Comprehensive CBT via reSET for a Hub and Spoke MAT System of Care$731,289
R33 · FY2019 · AT
NIDA Clinical Trials Network: Greater New York Node$420,013
UG1 · FY2019 · DA
NIDA Clinical Trials Network: Greater New York Node$380,441
UG1 · FY2019 · DA
NIDA Clinical Trials Network: Greater New York Node$229,649
UG1 · FY2019 · DA
NIDA Clinical Trials Network: Greater New York Node$212,814
UG1 · FY2019 · DA
NIDA Clinical Trials Network: Greater New York Node$207,676
UG1 · FY2019 · DA
Evaluation of safety and pharmacokinetics of naltrexone implant$101,428
UG3 · FY2019 · DA
NIDA Clinical Trials Network: Greater New York Node$35,922
UG1 · FY2019 · DA
Evaluation of safety and pharmacokinetics of naltrexone implant$3,010,138
UG3 · FY2018 · DA
NIDA Clinical Trials Network: Greater New York Node$2,165,120
UG1 · FY2018 · DA
NIDA Clinical Trials Network: Greater New York Node$773,828
UG1 · FY2018 · DA
Comprehensive CBT via reSET for a Hub and Spoke MAT System of Care$328,901
R21 · FY2018 · AT
NIDA Clinical Trials Network: Greater New York Node$239,002
UG1 · FY2018 · DA
NIDA Clinical Trials Network: Greater New York Node$98,813
UG1 · FY2018 · DA
NIDA Clinical Trials Network: Greater New York Node$55,294
UG1 · FY2018 · DA
NIDA Clinical Trials Network: Greater New York Node$47,890
UG1 · FY2018 · DA
NIDA Clinical Trials Network: Greater New York Node$2,483,943
UG1 · FY2017 · DA
NIDA Clinical Trials Network: Greater New York Node$1,231,502
UG1 · FY2017 · DA
NIDA Clinical Trials Network: Greater New York Node$791,029
UG1 · FY2017 · DA
NIDA Clinical Trials Network: Greater New York Node$465,130
UG1 · FY2017 · DA
NIDA Clinical Trials Network: Greater New York Node$361,191
UG1 · FY2017 · DA
NIDA Clinical Trials Network: Greater New York Node$54,999
UG1 · FY2017 · DA
NIDA Clinical Trials Network: Greater New York Node$3,006,654
UG1 · FY2016 · DA
Project-002$2,526,880
UG1 · FY2016 · DA
NIDA Clinical Trials Network: Greater New York Node$1,445,101
UG1 · FY2016 · DA
NIDA Clinical Trials Network: Greater New York Node$818,688
UG1 · FY2016 · DA
Project-003$479,774
UG1 · FY2016 · DA
NIDA Clinical Trials Network: Greater New York Node$475,663
UG1 · FY2016 · DA
NIDA Clinical Trials Network: Greater New York Node$287,880
UG1 · FY2016 · DA
Drug Abuse Treatment Development and Research Mentoring$170,546
K24 · FY2016 · DA · contact PI
Clinical Trials Network: Greater New York Node$1,970,018
U10 · FY2015 · DA · contact PI
NIDA Clinical Trials Network: Greater New York Node$1,116,411
UG1 · FY2015 · DA
NIDA Clinical Trials Network: Greater New York Node$871,690
UG1 · FY2015 · DA
NIDA Clinical Trials Network: Greater New York Node$710,815
UG1 · FY2015 · DA
Drug Abuse Treatment Development and Research Mentoring$170,546
K24 · FY2015 · DA · contact PI
Clinical Trials Network: Greater New York Node$1,839,069
U10 · FY2014 · DA · contact PI
Clinical Trials Network: Greater New York Node$1,417,362
U10 · FY2014 · DA · contact PI
Training Motivational Interviewing Using Live Supervision$540,981
R01 · FY2014 · DA · contact PI
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site$264,262
R01 · FY2014 · DA · contact PI
Drug Abuse Treatment Development and Research Mentoring$170,546
K24 · FY2014 · DA · contact PI
Clinical Trials Network: Greater New York Node$1,418,160
U10 · FY2013 · DA · contact PI
Clinical Trials Network: Greater New York Node$912,450
U10 · FY2013 · DA · contact PI
Clinical Trials Network: Greater New York Node$619,880
U10 · FY2013 · DA · contact PI
Training Motivational Interviewing Using Live Supervision$601,077
R01 · FY2013 · DA · contact PI
Clinical Trials Network: Greater New York Node$264,982
U10 · FY2013 · DA · contact PI
Drug Abuse Treatment Development and Research Mentoring$170,546
K24 · FY2013 · DA · contact PI
Clinical Trials Network: Greater New York Node$1,630,277
U10 · FY2012 · DA · contact PI
Clinical Trials Network: Greater New York Node$1,420,571
U10 · FY2012 · DA · contact PI
Clinical Trials Network: Greater New York Node$825,000
U10 · FY2012 · DA · contact PI
Training Motivational Interviewing Using Live Supervision$560,442
R01 · FY2012 · DA · contact PI
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site$363,369
R01 · FY2012 · DA · contact PI
Drug Abuse Treatment Development and Research Mentoring$170,546
K24 · FY2012 · DA · contact PI
Clinical Trials Network: Greater New York Node$1,429,091
U10 · FY2011 · DA · contact PI
Clinical Trials Network: Greater New York Node$1,055,724
U10 · FY2011 · DA · contact PI
Clinical Trials Network: Greater New York Node$970,323
U10 · FY2011 · DA · contact PI
Clinical Trials Network: Greater New York Node$937,369
U10 · FY2011 · DA · contact PI
Training Motivational Interviewing Using Live Supervision$561,673
R01 · FY2011 · DA · contact PI
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site$378,517
R01 · FY2011 · DA · contact PI
Drug Abuse Treatment Development and Research Mentoring$174,706
K24 · FY2011 · DA · contact PI
Clinical Trials Network: Greater New York Node$1,525,851
U10 · FY2010 · DA · contact PI
Clinical Trials Network: Greater New York Node$1,150,000
U10 · FY2010 · DA · contact PI
Training Motivational Interviewing Using Live Supervision$569,292
R01 · FY2010 · DA · contact PI
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site$381,909
R01 · FY2010 · DA · contact PI
Clinical Trials Network: Long Island Regional Node$232,114
U10 · FY2010 · DA · contact PI
Drug Abuse Treatment Development and Research Mentoring$174,775
K24 · FY2010 · DA · contact PI
Clinical Trials Network: Long Island Regional Node$1,537,731
U10 · FY2009 · DA · contact PI
Clinical Trials Network: Long Island Regional Node$1,239,360
U10 · FY2009 · DA · contact PI
Clinical Trials Network: Long Island Regional Node$690,196
U10 · FY2009 · DA · contact PI
Drug Abuse Treatment Development and Research Mentoring$174,841
K24 · FY2009 · DA · contact PI
Clinical Trials Network: Long Island Regional Node$100,001
U10 · FY2009 · DA · contact PI
Clinical Trials Network: Long Island Regional Node$1,993,912
U10 · FY2008 · DA · contact PI
Clinical Trials Network: Long Island Regional Node$1,250,000
U10 · FY2008 · DA · contact PI
New Approaches to Cocaine Abuse Medications$392,644
P50 · FY2008 · DA · contact PI
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site$380,536
R01 · FY2008 · DA · contact PI
Drug Abuse Treatment Development and Research Mentoring$174,908
K24 · FY2008 · DA · contact PI
CU PARTNERS: NY/LONG ISLAND REGIONAL NODE$2,293,442
U10 · FY2007 · DA · contact PI
Clinical Trials Network: Long Island Regional Node$1,250,000
U10 · FY2007 · DA · contact PI
New Approaches to Cocaine Abuse Medications$478,428
P50 · FY2007 · DA · contact PI
Drug Abuse Treatment Development and Research Mentoring$176,978
K24 · FY2007 · DA · contact PI
CU PARTNERS: NY/LONG ISLAND REGIONAL NODE$1,941,165
U10 · FY2006 · DA · contact PI
CU PARTNERS: NY/LONG ISLAND REGIONAL NODE$1,250,000
U10 · FY2006 · DA · contact PI
Opiate Dependence: Combined Naltrexone/Behavior Therapy$599,707
R01 · FY2006 · DA · contact PI
MI Training: Live Supervision by Tele-Conference$348,825
R01 · FY2006 · DA · contact PI
New Approaches to Cocaine Abuse Medications$305,679
P50 · FY2006 · DA · contact PI
CU PARTNERS: NY/LONG ISLAND REGIONAL NODE$2,504,463
U10 · FY2005 · DA
CU PARTNERS: NY/LONG ISLAND REGIONAL NODE$1,250,000
U10 · FY2005 · DA
MI Training: Live Supervision by Tele-Conference$378,367
R01 · FY2005 · DA
New Approaches to Cocaine Abuse Medications$300,410
P50 · FY2005 · DA
DRUG ABUSE PHARMACOTHERAPY: METHODOLOGIC INITIATIVES$123,055
K02 · FY2005 · DA
CU PARTNERS: NY/LONG ISLAND REGIONAL NODE$1,500,000
U10 · FY2004 · DA
CU PARTNERS: NY/LONG ISLAND REGIONAL NODE$1,381,071
U10 · FY2004 · DA
OPIATE DEPENDENCE: COMBINED NALTREXONE/BEHAVIOR THERAPY$558,169
R01 · FY2004 · DA
MI Training: Live Supervision by Tele-Conference$374,628
R01 · FY2004 · DA
New Approaches to Cocaine Abuse Medications$289,276
P50 · FY2004 · DA
DRUG ABUSE PHARMACOTHERAPY: METHODOLOGIC INITIATIVES$122,861
K02 · FY2004 · DA
OPIATE DEPENDENCE: COMBINED NALTREXONE/BEHAVIOR THERAPY$116,675
R01 · FY2004 · DA
CU PARTNERS: NY/LONG ISLAND REGIONAL NODE$1,940,956
U10 · FY2003 · DA
CU PARTNERS: NY/LONG ISLAND REGIONAL NODE$1,500,000
U10 · FY2003 · DA
OPIATE DEPENDENCE: COMBINED NALTREXONE/BEHAVIOR THERAPY$542,542
R01 · FY2003 · DA
MI Training: Live Supervision by Tele-Conference$345,998
R01 · FY2003 · DA
DRUG ABUSE PHARMACOTHERAPY: METHODOLOGIC INITIATIVES$122,666
K02 · FY2003 · DA
CU PARTNERS: NY/LONG ISLAND REGIONAL NODE$1,800,000
U10 · FY2002 · DA
OPIATE DEPENDENCE: COMBINED NALTREXONE/BEHAVIOR THERAPY$527,367
R01 · FY2002 · DA
CU PARTNERS: NY/LONG ISLAND REGIONAL NODE$359,808
U10 · FY2002 · DA
BEHAVIORAL THERAPY FOR DEPRESSION IN DRUG DEPENDENCE$226,196
R01 · FY2002 · DA
DRUG ABUSE PHARMACOTHERAPY: METHODOLOGIC INITIATIVES$122,472
K02 · FY2002 · DA
Excitatory and Inhibitory Pathways for Cocaine Treatment$0
P50 · FY2002 · DA
NEW APPROACHES TO COCAINE ABUSE MEDICATIONS$0
P50 · FY2002 · DA
CU PARTNERS: NY/LONG ISLAND REGIONAL NODE$2,200,000
U10 · FY2001 · DA
OPIATE DEPENDENCE: COMBINED NALTREXONE/BEHAVIOR THERAPY$512,633
R01 · FY2001 · DA
BEHAVIORAL THERAPY FOR DEPRESSION IN DRUG DEPENDENCE$227,402
R01 · FY2001 · DA
OPIATE DEPENDENCE: COMBINED NALTREXONE/BEHAVIOR THERAPY$129,973
R01 · FY2001 · DA
DRUG ABUSE PHARMACOTHERAPY: METHODOLOGIC INITIATIVES$122,276
K02 · FY2001 · DA
Excitatory and Inhibitory Pathways for Cocaine Treatment$0
P50 · FY2001 · DA
NEW APPROACHES TO COCAINE ABUSE MEDICATIONS$0
P50 · FY2001 · DA
OPIATE DEPENDENCE: COMBINED NALTREXONE/BEHAVIOR THERAPY$498,852
R01 · FY2000 · DA
NEW APPROACHES TO COCAINE ABUSE MEDICATIONS$313,799
P50 · FY2000 · DA
NEW APPROACHES TO COCAINE ABUSE MEDICATIONS$313,799
P50 · FY2000 · DA
Excitatory and Inhibitory Pathways for Cocaine Treatment$228,628
P50 · FY2000 · DA
BEHAVIORAL THERAPY FOR DEPRESSION IN DRUG DEPENDENCE$221,809
R01 · FY2000 · DA
DRUG ABUSE PHARMACOTHERAPY--METHODOLGIC INITIATIVES$108,135
K02 · FY2000 · DA